Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
2008
2009
2010
Announcements
Articles
Articles and Publications
Campaign
Case Studies
Charge Capture and Pricing
Coding Integrity
Company
Craneware Insights Articles
Directors
Education
Home
Journey
Opportunities
Other
post
Press Releases
Products
Testimonial
Trade Shows
Uncategorized
Upcoming Events
Webinars
White Papers

Director Shareholding

31 January 2017 – Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, has been informed that Keith Neilson, CEO of the Company, yesterday transferred 49,800 ordinary shares of 1 pence each in the Company (“Ordinary Shares”) at a price of 1,305 pence per share. Mr. Neilson transferred the shares from his holding to the Neilson Family Foundation, a charity trust set up for the future benefit of medical research and Young People’s charities, to which Mr. Neilson is the sole adviser with regards to voting and holding rights.

Following this transaction, Mr. Neilson’s beneficial interest in Craneware has reduced to 3,459,718 Ordinary Shares, representing approximately 12.8% of the Company’s issued Ordinary Share capital.

For further information, please contact:

Craneware plc

Peel Hunt

  • +44 (0)20 7418 8900
  • Dan Webster
  • Adrian Trimmings
  • George Sellar

Alma

  • +44 (0)208 004 4218
  • Caroline Forde
  • Hilary Buchanan
  • Robyn McConnachie

About Craneware

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Craneware is the leader in automated value cycle solutions that help US provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 200 staff. Craneware’s market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.